Western Health Advantage |
Kisqali (600 MG Dose) (ribociclib) |
Drugs for Cancer : Drugs for Cancer |
- 1;
- PA Applies
- PA Required
- Solid Tumor with NTRK Gene Fusion:
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: Yes
Reauthorization Required: No
Duration of Reauthorization: N/A
Specialty Pharmacy is Required: Not Defined
|